Tech Company Financing Transactions
Scipher Medicine Funding Round
On 2/20/2020, Scipher Medicine received $25 million in Series B financing from Optum Ventures.
Transaction Overview
Company Name
Announced On
2/20/2020
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
Optum Ventures' investment, along with other Series B investments, will help accelerate its work on PrismRA and further its expansion into other difficult-to-treat and complex disease areas.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
303 Wyman St.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Not Recorded
Overview
Scipher Medicine is determined to ensure that patients are given access to drugs that work effectively -- from day one. Its molecular technology platform predicts accurately whether a patient will respond to a particular therapy. For patients who don't respond to existing drugs, the platform identifies new targets that can be used to develop more effective therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alif Saleh
Chief Technical Officer
Slava Akmaev
Co-Founder
Albert Barabási
Co-Founder
Joseph Loscalzo
VP - General Counsel
Jeffrey Sachs
VP - Human Resources
Alison Stowell
VP - Marketing
Jerry Conway
VP - Sales
Brian McEvilly
Browse more venture capital transactions:
Prev: 2/20/2020: Arize AI venture capital transaction
Next: 2/20/2020: Outrider venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs